271 related articles for article (PubMed ID: 9652942)
21. Understanding autism.
Cowley G
Newsweek; 2000 Jul; 136(5):46-54. PubMed ID: 11009739
[No Abstract] [Full Text] [Related]
22. Autism, inflammatory bowel disease, and MMR vaccine.
Tettenborn MA
Lancet; 1998 May; 351(9112):1357. PubMed ID: 9643821
[No Abstract] [Full Text] [Related]
23. Autism, inflammatory bowel disease, and MMR vaccine.
Walker-Smith JA
Lancet; 1998 May; 351(9112):1356-7. PubMed ID: 9643819
[No Abstract] [Full Text] [Related]
24. Reactions to MMR immunization scare.
Birmingham K; Cimons M
Nat Med; 1998 May; 4(5 Suppl):478-9. PubMed ID: 9585188
[No Abstract] [Full Text] [Related]
25. Autism, inflammatory bowel disease, and MMR vaccine.
Kiln MR
Lancet; 1998 May; 351(9112):1358. PubMed ID: 9643823
[No Abstract] [Full Text] [Related]
26. The MMR question.
Iizuka M; Itou H; Chiba M; Shirasaka T; Watanabe S
Lancet; 2000 Jul; 356(9224):160. PubMed ID: 10963263
[No Abstract] [Full Text] [Related]
27. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study.
Peltola H; Patja A; Leinikki P; Valle M; Davidkin I; Paunio M
Lancet; 1998 May; 351(9112):1327-8. PubMed ID: 9643797
[No Abstract] [Full Text] [Related]
28. Fall in MMR vaccine coverage reported as further evidence of vaccine safety is published.
Commun Dis Rep CDR Wkly; 1999 Jun; 9(26):227, 230. PubMed ID: 10425812
[No Abstract] [Full Text] [Related]
29. Autism, inflammatory bowel disease, and MMR vaccine.
Lee JW; Melgaard B; Clements CJ; Kane M; Mulholland EK; Olivé JM
Lancet; 1998 Mar; 351(9106):905; author reply 908-9. PubMed ID: 9525390
[No Abstract] [Full Text] [Related]
30. MMR vaccine coverage shows signs of recovery.
Commun Dis Rep CDR Wkly; 1999 Sep; 9(39):345. PubMed ID: 10510563
[No Abstract] [Full Text] [Related]
31. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.
Vlacha V; Forman EN; Miron D; Peter G
Pediatrics; 1996 May; 97(5):738-9. PubMed ID: 8628619
[No Abstract] [Full Text] [Related]
32. The MMR question.
Elphinstone P
Lancet; 2000 Jul; 356(9224):161. PubMed ID: 10963265
[No Abstract] [Full Text] [Related]
33. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association.
DeStefano F; Chen RT
J Pediatr; 2000 Jan; 136(1):125-6. PubMed ID: 10681219
[No Abstract] [Full Text] [Related]
34. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.
Taylor B; Miller E; Farrington CP; Petropoulos MC; Favot-Mayaud I; Li J; Waight PA
Lancet; 1999 Jun; 353(9169):2026-9. PubMed ID: 10376617
[TBL] [Abstract][Full Text] [Related]
35. Autism, inflammatory bowel disease, and MMR vaccine.
Black D; Prempeh H; Baxter T
Lancet; 1998 Mar; 351(9106):905-6; author reply 908-9. PubMed ID: 9525391
[No Abstract] [Full Text] [Related]
36. The MMR question.
Thrower D
Lancet; 2000 Jul; 356(9224):161. PubMed ID: 10963266
[No Abstract] [Full Text] [Related]
37. Autism, inflammatory bowel disease, and MMR vaccine.
O'Brien SJ; Jones IG; Christie P
Lancet; 1998 Mar; 351(9106):906-7; author reply 908-9. PubMed ID: 9525393
[No Abstract] [Full Text] [Related]
38. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(28):603-6. PubMed ID: 8676852
[TBL] [Abstract][Full Text] [Related]
39. The MMR vaccine debate.
Community Nurse; 1998 Oct; 4(9):12-3. PubMed ID: 10326363
[No Abstract] [Full Text] [Related]
40. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
